Annual Drug Patent Expirations for OSMOLEX+ER Osmolex Er is a drug marketed by Osmotica Pharm and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Osmotica Pharm drug OSMOLEX ER appeared first on DrugP…
Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29 Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Abbvie Inc drug VIEKIRA PAK (COP…
Annual Drug Patent Expirations for ONEXTON Onexton is a drug marketed by Dow Pharm and is included in one NDA. It is available from three suppliers. There are four patents…
The post New patent for Dow Pharm drug ONEXTON appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for RAYALDEE Rayaldee is a drug marketed by Opko Ireland Global and is included in one NDA. It is available from one supplier. There are eleven…
The post New patent for Opko Ireland drug RAYALDEE appeared first on DrugPat…
Annual Drug Patent Expirations for ACANYA Acanya is a drug marketed by Dow Pharm and is included in one NDA. It is available from three suppliers. There are four patents…
The post New patent for Dow Pharm drug ACANYA appeared first on DrugPatentWatch -…
Annual Drug Patent Expirations for INVELTYS Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Kala Pharms drug INVELTYS appeared first on DrugPa…
Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are eleven patents…
The post New patent for Helsinn Hlthcare drug AKYNZEO appeared first on …
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are seventeen…
The post New patent for Novo Nordisk drug SAXENDA appeared first on DrugPatent…
Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent for Allergan Holdings drug VIBERZI appeared first on…
Annual Drug Patent Expirations for HEMANGEOL Hemangeol is a drug marketed by Pierre Fabre Derma and is included in one NDA. It is available from one supplier. There is one…
The post New patent for Pierre Fabre drug HEMANGEOL appeared first on DrugPaten…